Comprehensive genomic analyses of T-ALL have identified activating mutations in IL7R, JAK1, JAK3, and/or STAT5 in approximately 20–30% of cases, with a higher frequency observed in ETP-ALL subtypes [97]. The gene discussed is IL7R; the disease is acute lymphoblastic leukemia.